The missionof the center is to discover and develop various technologies and products that can be used to reliably alert and efficiently prevent the potential cancer metastasis after surgical removal of primary cancers. Therefore, patients can be relieved from fear of potential cancer metastasis, and cancer death rate can be significantly reduced. To fulfill the mission, our workwill focus on 1) studying the mechanisms of cancer metastasis after surgery from cellular and molecular basis as well as from mammal body as a whole; 2) discovering key pathways that control cancer metastasis; 3) establishing animal models that can reliably mimic metastasis in patients. After comprehensive understanding of metastasis dynamics, internal and external elements that deactivate or reactivate circulating tumor cells, we will develop various methods, techniques and products that can reliably alert metastasis for cancer survivors; develop various techniques and products (including drug combination, nanomaterials, biopharmaceuticals, traditional Chinese medicines, acupunctures and others) that can efficiently and safely prevent cancer survivors from potential metastasis. To carry on these tasks, the center seeks for private and governmental research funds at home and abroad. In return, the center will deliver its own products to cancer survivors, and integrate their products with global knowledge and technology to educate and reimburse cancer survivors.

Three months after signing off the National Cancer  Act, President Nixon visited China on Feb. 21, 1972. He met with the then Chinese Prime Minister Zhou EnLai, who died of prostate cancer  at age 78 (Jan. 8, 1976).